key: cord-0808414-0oz4zg59
authors: Franzini, Andrea; Attuati, Luca; Fornari, Maurizio; Servadei, Franco; Navarria, Pierina; Picozzi, Piero
title: Performing Gamma Knife radiosurgery safely during the COVID-19 pandemic: preliminary results from a single center in the Lombardy region in Italy
date: 2020-05-18
journal: Acta Neurochir (Wien)
DOI: 10.1007/s00701-020-04400-y
sha: db6f2879adc39cdc160e00c53253b86617e1b40b
doc_id: 808414
cord_uid: 0oz4zg59

nan

intracranial pathology. [3] Notably, patients with brain metastases are at risk, as a delay in treatment would affect their longterm prognoses. On the other hand, we had to prevent our patients from nosocomial infection with COVID-19 that could become life-threatening. [2] There was a significant risk to these patients as our hospital was filled with over 300 patients being treated for COVID-19, as well as many healthcare workers who were likely carrying the virus while asymptomatic. Therefore, we decided to treat those patients by utilizing a treatment pathway that was still able to ensure patient safety.

Some precautions were used. Only one patient was treated per day (usually two patients are treated with GK radiosurgery per day at our center). All healthcare workers who came into contact with the patient, including the treating neurosurgeon and nurses, were excluded from treating patients with COVID-19 and from being in COVID-19 units. These workers and patients also wore appropriate personal protective equipment, including gloves and facemasks, during all steps of the GK procedure.

Our treatment pathway for GK radiosurgery was performed as an outpatient procedure that spanned 2 days. During the first day, the patient underwent COVID-19 nasopharyngeal swab, chest-computed tomography (CT), routine blood tests, and an infrared body temperature check. The second day, if all those exams and physical examination had ruled out COVID-19 infection and related syndromes, the patient was admitted to the GK center. After arrival, the patient washed his/her hands with hand sanitizer and stored in a locker all personal belongings. Peripheral pulse oximetry was placed to assess oxygenation status, and the stereotactic head frame was fixed. The patient was transferred to radiology procedural suit and back by traveling on a wheelchair. Stereotactic magnetic resonance imaging was acquired, and radiosurgery was performed with the Leksell GK Perfexion (Elekta AB instruments, Stockholm, Sweden). At the end of the procedure, the frame was removed, and the patient was discharged home. Finally, the GK and radiology rooms were sanitized and disinfected carefully.

Since the beginning of the outbreak in late February 2020, we have treated 12 patients with single or multiple brain metastases at our GK unit (seven new and five repeat treatments). At the end of April 2020, the authors confirmed via telephone interview that none of these patients developed COVID-19 pneumonia and that all were still alive. The number of patients treated has been considerably reduced during the pandemic than routinely, as an average number of 40 patients is usually treated with GK radiosurgery per month at our center.

Several aspects favor GK radiosurgery in the current pandemic setting. It can be performed in outpatient setting as a single-session procedure, opposite to conventionally fractionated radiotherapy, which requires between 10 and 30 hospital visits. Second, GK radiosurgery does not require endotracheal intubation or the use of high-speed instruments, lowering the risk of exposure to infectious aerosols and bone dust present in open surgical procedures. [2] Treating patients at their oncological reference center instead of being referred to distant centers is also relevant. As an example, we are able to make direct online comparison between a patient's latest brain imaging and stored exams/plans using the Leksell GammaPlan software (Elekta AB instruments, Stockholm, Sweden). This allows to distinguish new metastatic lesions from remnants of previous treatments or presumed radiation necrosis, as well as to make more accurate dosimetric prescriptions together with our radiotherapists and medical physicists. Finally, patients can be directly assessed by their personal oncologist while at their reference center.

Our protocol for performing GK radiosurgery during the COVID-19 outbreak has demonstrated to be safe and could be extended to other outpatient neurosurgical procedures. Notably, this treatment pathway could be adopted by other GK units working in the vicinity of a COVID-19 outbreak without having to transfer patients to distant centers.

Neurosurgery in the storm of COVID-19: suggestions from the Lombardy region, Italy (ex malo bonum)

Baseline Characteristics and outcomes of 1591 patients infected with sars-CoV-2 admitted to ICUs of the Lombardy Region

Letter: COVID-19 pandemic: safety precautions for stereotactic radiosurgery

Neurosurgery during the COVID-19 pandemic: update from Lombardy, northern Italy

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Acknowledgments The authors thank Dr. Shayan Moosa, MD (University of Virginia, Charlottesville, Virginia, USA) for the English language edits.

The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.Informed consent The patients have consented to submission of this letter to the journal.Abbreviations GK, gamma knife; CT, computed tomography